Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Feb;64(2):235–238. doi: 10.1136/ard.2004.021105

No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis

M van der Paardt 1, J Crusius 1, M H M T de Koning 1, S Morre 1, R J van de Stadt 1, B Dijkmans 1, A Pena 1, I E van der Horst-Bru 1
PMCID: PMC1755347  PMID: 15647432

Abstract

Objectives: Ankylosing spondylitis (AS) is a multifactorial and polygenic disease. Apart from HLA, other genes very probably play a role in disease susceptibility. Indigenous bacteria of the gastrointestinal flora appear to play a role in the pathogenesis of the disease; therefore, genes controling the innate and acquired immune response are good candidates to study disease susceptibility. CD14 and Toll-like receptor 4 (TLR4) are key receptors for the sensing of bacteria. The CD14 C-260T and TLR4 A896G single nucleotide polymorphims are associated with aberrant signal transduction for bacterial agonists.

Methods: The distribution of the CD14 C-260T and TLR4 A896G polymorphisms was studied in genomic DNA from 113 unrelated white Dutch AS patients and 170 ethnically matched healthy controls. The diagnosis of AS was made according to the modified New York criteria. The CD14 C-260T and TLR4 A896G polymorphisms were genotyped by PCR-RFLP methods.

Results: No significant differences were found between patients and controls in the frequencies of the carriership of the less frequent CD14-260T allele (odds ratio 0.65; 95% confidence interval 0.37 to 1.15) or the TLR4 896G allele (1.68; 0.67 to 4.19).

Conclusions: There is no evidence for involvement of the CD14 C-260T or TLR4 A896G polymorphisms in susceptibility to AS. An important role of bacteria and genetic predisposition of the innate immune system in cases of AS cannot be excluded by these findings. Therefore, studies of the surprisingly highly polymorphic candidate genes in this field should be continued.

Full Text

The Full Text of this article is available as a PDF (177.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbour N. C., Lorenz E., Schutte B. C., Zabner J., Kline J. N., Jones M., Frees K., Watt J. L., Schwartz D. A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000 Jun;25(2):187–191. doi: 10.1038/76048. [DOI] [PubMed] [Google Scholar]
  2. Baeten D., De Keyser F., Van Damme N., Veys E. M., Mielants H. Influence of the gut and cytokine patterns in spondyloarthropathy. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S38–S42. [PubMed] [Google Scholar]
  3. Baeten Dominique, De Keyser Filip, Mielants Herman, Veys Eric M. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):537–549. doi: 10.1053/berh.2002.0249. [DOI] [PubMed] [Google Scholar]
  4. Baldini M., Lohman I. C., Halonen M., Erickson R. P., Holt P. G., Martinez F. D. A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999 May;20(5):976–983. doi: 10.1165/ajrcmb.20.5.3494. [DOI] [PubMed] [Google Scholar]
  5. Beutler B. A. The role of tumor necrosis factor in health and disease. J Rheumatol Suppl. 1999 May;57:16–21. [PubMed] [Google Scholar]
  6. Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity. 2001 Jul;15(1):5–14. doi: 10.1016/s1074-7613(01)00176-5. [DOI] [PubMed] [Google Scholar]
  7. Brewerton D. A., Hart F. D., Nicholls A., Caffrey M., James D. C., Sturrock R. D. Ankylosing spondylitis and HL-A 27. Lancet. 1973 Apr 28;1(7809):904–907. doi: 10.1016/s0140-6736(73)91360-3. [DOI] [PubMed] [Google Scholar]
  8. Burmester G. R., Daser A., Kamradt T., Krause A., Mitchison N. A., Sieper J., Wolf N. Immunology of reactive arthritides. Annu Rev Immunol. 1995;13:229–250. doi: 10.1146/annurev.iy.13.040195.001305. [DOI] [PubMed] [Google Scholar]
  9. Chow J. C., Young D. W., Golenbock D. T., Christ W. J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999 Apr 16;274(16):10689–10692. doi: 10.1074/jbc.274.16.10689. [DOI] [PubMed] [Google Scholar]
  10. Crane Alison M., Bradbury Linda, van Heel David A., McGovern Dermot P. B., Brophy Sinead, Rubin Laurence, Siminovitch Katherine A., Wordsworth B. Paul, Calin Andrei, Brown Matthew A. Role of NOD2 variants in spondylarthritis. Arthritis Rheum. 2002 Jun;46(6):1629–1633. doi: 10.1002/art.10329. [DOI] [PubMed] [Google Scholar]
  11. Erridge Clett, Stewart John, Poxton Ian R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med. 2003 Jun 9;197(12):1787–1791. doi: 10.1084/jem.20022078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ferreirós-Vidal Isabel, Amarelo Juan, Barros Francisco, Carracedo Angel, Gómez-Reino Juan J., Gonzalez Antonio. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J Rheumatol. 2003 Jan;30(1):102–104. [PubMed] [Google Scholar]
  13. Hampe J., Cuthbert A., Croucher P. J., Mirza M. M., Mascheretti S., Fisher S., Frenzel H., King K., Hasselmeyer A., MacPherson A. J. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001 Jun 16;357(9272):1925–1928. doi: 10.1016/S0140-6736(00)05063-7. [DOI] [PubMed] [Google Scholar]
  14. Hoffman I. E. A., Demetter P., Peeters M., De Vos M., Mielants H., Veys E. M., De Keyser F. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis. 2003 May;62(5):455–459. doi: 10.1136/ard.62.5.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hubacek J. A., Rothe G., Pit'ha J., Skodová Z., Stanek V., Poledne R., Schmitz G. C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999 Jun 29;99(25):3218–3220. doi: 10.1161/01.cir.99.25.3218. [DOI] [PubMed] [Google Scholar]
  16. Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., Almer S., Tysk C., O'Morain C. A., Gassull M. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):599–603. doi: 10.1038/35079107. [DOI] [PubMed] [Google Scholar]
  17. Klein W., Tromm A., Griga T., Folwaczny C., Hocke M., Eitner K., Marx M., Duerig N., Epplen J. T. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol. 2003 Aug;38(8):834–836. doi: 10.1080/00365520310003147. [DOI] [PubMed] [Google Scholar]
  18. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., Eitner K., Marx M., Duerig N., Epplen J. T. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol. 2002 Feb;37(2):189–191. doi: 10.1080/003655202753416867. [DOI] [PubMed] [Google Scholar]
  19. Laval S. H., Timms A., Edwards S., Bradbury L., Brophy S., Milicic A., Rubin L., Siminovitch K. A., Weeks D. E., Calin A. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001 Feb 27;68(4):918–926. doi: 10.1086/319509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LeVan T. D., Bloom J. W., Bailey T. J., Karp C. L., Halonen M., Martinez F. D., Vercelli D. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol. 2001 Nov 15;167(10):5838–5844. doi: 10.4049/jimmunol.167.10.5838. [DOI] [PubMed] [Google Scholar]
  21. Morré Servaas A., Murillo Laura S., Spaargaren Joke, Fennema Han S. A., Peña A. Salvador. Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis. 2002 Nov 1;186(9):1377–1379. doi: 10.1086/344328. [DOI] [PubMed] [Google Scholar]
  22. Murillo Laura, Crusius J. Bart A., van Bodegraven Ad A., Alizadeh Behrooz Z., Peña A. Salvador. CARD15 gene and the classification of Crohn's disease. Immunogenetics. 2002 Mar 2;54(1):59–61. doi: 10.1007/s00251-002-0440-1. [DOI] [PubMed] [Google Scholar]
  23. Obana N., Takahashi S., Kinouchi Y., Negoro K., Takagi S., Hiwatashi N., Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol. 2002 Jun;37(6):699–704. doi: 10.1080/00365520212504. [DOI] [PubMed] [Google Scholar]
  24. Ogura Y., Bonen D. K., Inohara N., Nicolae D. L., Chen F. F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R. H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):603–606. doi: 10.1038/35079114. [DOI] [PubMed] [Google Scholar]
  25. Palm Oyvind, Moum Bjørn, Ongre Aksel, Gran Jan Tore. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol. 2002 Mar;29(3):511–515. [PubMed] [Google Scholar]
  26. Peña A. S. Genetics of inflammatory bowel diseases--past, present, and future. Dig Dis. 2003;21(2):85–90. doi: 10.1159/000073241. [DOI] [PubMed] [Google Scholar]
  27. Repo Heikki, Anttonen Krista, Kilpinen Sami K., Palotie Aarno, Salven Petri, Orpana Arto, Leirisalo-Repo Marjatta. CD14 and TNfa promoter polymorphisms in patients with acute arthritis. Special reference to development of chronic spondyloarthropathy. Scand J Rheumatol. 2002;31(6):355–361. doi: 10.1080/030097402320817086. [DOI] [PubMed] [Google Scholar]
  28. Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973 Apr 5;288(14):704–706. doi: 10.1056/NEJM197304052881403. [DOI] [PubMed] [Google Scholar]
  29. Taurog J. D., Richardson J. A., Croft J. T., Simmons W. A., Zhou M., Fernández-Sueiro J. L., Balish E., Hammer R. E. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994 Dec 1;180(6):2359–2364. doi: 10.1084/jem.180.6.2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vabulas R. M., Ahmad-Nejad P., da Costa C., Miethke T., Kirschning C. J., Häcker H., Wagner H. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001 Jun 11;276(33):31332–31339. doi: 10.1074/jbc.M103217200. [DOI] [PubMed] [Google Scholar]
  31. Vercelli D. Learning from discrepancies: CD14 polymorphisms, atopy and the endotoxin switch. Clin Exp Allergy. 2003 Feb;33(2):153–155. doi: 10.1046/j.1365-2222.2003.01606.x. [DOI] [PubMed] [Google Scholar]
  32. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]
  33. da Silva Correia J., Soldau K., Christen U., Tobias P. S., Ulevitch R. J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem. 2001 Mar 26;276(24):21129–21135. doi: 10.1074/jbc.M009164200. [DOI] [PubMed] [Google Scholar]
  34. van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361–368. doi: 10.1002/art.1780270401. [DOI] [PubMed] [Google Scholar]
  35. van der Paardt M., Crusius J. B. A., de Koning M. H. M. T., Murillo L. S., van de Stadt R. J., Dijkmans B. A. C., Peña A. S., van der Horst-Bruinsma I. E. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun. 2003 Jan;4(1):77–78. doi: 10.1038/sj.gene.6363914. [DOI] [PubMed] [Google Scholar]
  36. van der Paardt M., van Denderen J. C., van den Brule A. J., Morré S. A., van der Horst-Bruinsma I. E., Bezemer P. D., Dijkmans B. A. Prevalence of Chlamydia trachomatis in urine of male patients with ankylosing spondylitis is not increased. Ann Rheum Dis. 2000 Apr;59(4):300–302. doi: 10.1136/ard.59.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. von Aulock Sonja, Schröder Nicolas W. J., Gueinzius Katja, Traub Stephanie, Hoffmann Sebastian, Graf Kathrin, Dimmeler Stefanie, Hartung Thomas, Schumann Ralf R., Hermann Corinna. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis. 2003 Aug 28;188(6):938–943. doi: 10.1086/378095. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES